Roche (Nutley, NJ) recently announced that the FDA has approved labeling for use of the prescription weight-loss medication Xenical (orlistat) in the management of obese adolescents aged 12 to 16 years. This approval offers physicians and parents of overweight and obese adolescents a safe and effective treatment option to help manage their weight. Xenical works locally in the stomach to prevent dietary fat absorption by approximately 30%. It helps the patient lose weight as well as maintain the weight loss. For more information, visit www.xenical.com.